These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 18635189)
1. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese. Ueba T; Nomura S; Nishikawa T; Kajiwara M; Yamashita K Atherosclerosis; 2009 Mar; 203(1):243-8. PubMed ID: 18635189 [TBL] [Abstract][Full Text] [Related]
2. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study. Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651 [TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease. Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113 [TBL] [Abstract][Full Text] [Related]
5. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Holvoet P; Harris TB; Tracy RP; Verhamme P; Newman AB; Rubin SM; Simonsick EM; Colbert LH; Kritchevsky SB Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1444-8. PubMed ID: 12791672 [TBL] [Abstract][Full Text] [Related]
7. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. Lapointe A; Couillard C; Piché ME; Weisnagel SJ; Bergeron J; Nadeau A; Lemieux S Atherosclerosis; 2007 Apr; 191(2):362-8. PubMed ID: 16677652 [TBL] [Abstract][Full Text] [Related]
8. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640 [TBL] [Abstract][Full Text] [Related]
9. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. Ueba T; Nomura S; Inami N; Nishikawa T; Kajiwara M; Iwata R; Yamashita K J Atheroscler Thromb; 2010 Apr; 17(4):342-9. PubMed ID: 20379056 [TBL] [Abstract][Full Text] [Related]
10. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830 [TBL] [Abstract][Full Text] [Related]
11. Comparison of metabolic syndrome subjects with and without erectile dysfunction - levels of circulating oxidised LDL and arterial elasticity. Pohjantähti-Maaroos H; Palomäki A Int J Clin Pract; 2011 Mar; 65(3):274-80. PubMed ID: 21314864 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome. Imazu M; Ono K; Tadehara F; Kajiwara K; Yamamoto H; Sumii K; Tasaki N; Oiwa J; Shimohara Y; Gomyo Y; Itabe H Int Heart J; 2008 Sep; 49(5):515-24. PubMed ID: 18971563 [TBL] [Abstract][Full Text] [Related]
13. Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models. Pohjantähti-Maaroos H; Palomäki A; Kankkunen P; Husgafvel S; Knuth T; Vesterinen K; Oksanen K Ann Med; 2012 Aug; 44(5):503-12. PubMed ID: 21726125 [TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Holvoet P; Kritchevsky SB; Tracy RP; Mertens A; Rubin SM; Butler J; Goodpaster B; Harris TB Diabetes; 2004 Apr; 53(4):1068-73. PubMed ID: 15047623 [TBL] [Abstract][Full Text] [Related]
15. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. Onat A; Can G; Hergenç G; Uğur M; Yüksel H Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565 [TBL] [Abstract][Full Text] [Related]
17. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women. Tonstad S; Hjermann I J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910 [TBL] [Abstract][Full Text] [Related]
18. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Shimada K; Mokuno H; Matsunaga E; Miyazaki T; Sumiyoshi K; Miyauchi K; Daida H Atherosclerosis; 2004 Jun; 174(2):343-7. PubMed ID: 15136065 [TBL] [Abstract][Full Text] [Related]
19. Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome. Park SH; Kim JY; Lee JH; Park HY Clin Chim Acta; 2011 Feb; 412(5-6):435-40. PubMed ID: 21093421 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]